4582

Schering-Plough agreed to pay 91.6 million to settle multistate litigation alleging it engaged in illegal sales and marketing programs of its drugs Temodar and Intron A and that it engaged in Medicaid fraud irelating to its Claritin RediTabs and K-Dur products. This was part of a larger 435 million civil and criminal settlement involving the federal government; ###-schering-plough-corporation-3